Q: Where do you see rheumatology 10 years from now?
A: There’s a lot of interest in rheumatology and in medicine in general [in] using various strategies to collect and integrate lots of data on our patients so we can better understand what’s going on with them. This is highlighted by the recent [National Institutes of Health Accelerating Medicines Partnership], for example, that includes initiatives in rheumatology and other disciplines, which in all cases will involve the collection of tremendous amounts of raw data. I do think the challenge for us in the next 10 years is to figure out how to use these data in an integrative fashion to diagnose, understand and treat rheumatic diseases.
Richard Quinn is a freelance writer in New Jersey.
